PROPEL SINUS IMPLANT 70011

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative,health report with the FDA on 2015-08-28 for PROPEL SINUS IMPLANT 70011 manufactured by Intersect Ent.

Event Text Entries

[24516417] Attempts were made to contact the physician to request additional details in regard to this event, no response was received. The physician indicated that the patient needs revision surgery; however, it is unknown at this time, whether the patient has had revision surgery or has received any other treatment. Middle turbinate lateralization is a condition that may occur post-sinus surgery and is not likely to cause any detrimental effect in patients. It may impair visualization of the sinus cavity or if more severe may obstruct nasal drainage increasing the chance of sinus infections, however will not impair breathing. Thus, it is not likely that mt lateralization will cause or contribute to permanent impairment of body function or permanent damage to a body structure. The implant is intended to be used in conjunction with standard post-ess care, patient management is at the physician's discretion. Due to the limited information the company is taking a conservative approach in reporting this event. Date of the event: (b)(6) 2015. The following is being provided as this device is a combination product: name: propel, dose, frequency & route used: (1) 370 ug implant, diagnosis for use: sinus surgery. Combination product -yes.
Patient Sequence No: 1, Text Type: N, H10


[24516418] The patient underwent endoscopic sinus surgery (ess) including bilateral total full ethmoidectomy, frontal sinusotomy, and inferior turbinate resection, resulting in a significant tissue removal. The sinus implant was placed in the ethmoid sinus bilaterally per instructions for use (ifu). Physician instructed the patient to routinely irrigate. No post-operative visits were scheduled. The patient returned to see the physician 15 days post-operatively. The physician reported that the implant was not present, and the middle turbinate (mt) had scared to the lateral nasal wall bilaterally. The implant might have prematurely migrated and been expelled. The patient has been set up for revision surgery. (refer to mfr report # 3010101669-2015-00004 for other implant)
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3010101669-2015-00005
MDR Report Key5040130
Report SourceCOMPANY REPRESENTATIVE,HEALTH
Date Received2015-08-28
Date of Report2015-08-02
Date Mfgr Received2015-08-02
Device Manufacturer Date2015-04-09
Date Added to Maude2015-08-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS AMY WOLBECK
Manufacturer Street1555 ADAMS DR
Manufacturer CityMENLO PARK CA 94025
Manufacturer CountryUS
Manufacturer Postal94025
Manufacturer Phone6506412115
Manufacturer G1INTERSECT ENT
Manufacturer Street1555 ADAMS DR
Manufacturer CityMENLO PARK CA 94025
Manufacturer CountryUS
Manufacturer Postal Code94025
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NamePROPEL SINUS IMPLANT
Generic NameDRUG ELUTING SINUS STENT
Product CodeOWO
Date Received2015-08-28
Model Number70011
Catalog Number70011
Lot Number50409004
Device Expiration Date2016-10-09
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerINTERSECT ENT
Manufacturer AddressMENLO PARK CA US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2015-08-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.